CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 119 enrolled
Drug / intervention
electromagnetic placement devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06239610
NCT06239610N/ACompleted

DrIFT 2 Study: Displacement in Feeding Tubes

Parkview Health·interventional·Posted Feb 2, 2024·Updated Aug 11, 2025

In Brief

A clinical study evaluating electromagnetic placement device for Enteral Nutrition. Completed, enrolled 119 participants across 1 site.

Detailed Summary

The proposed study will use an electromagnetic placement device (EMPD), Cortrak\* 2 Enteral Access System (EAS™), Avanos Medical, to verify feeding tube (FT) position on a daily basis to assess for migration. The EMPD provides real-time FT placement data. A sensor located on the distal end of the FT guidewire communicates with a receiver unit which sits on the patient's abdomen. Three visual insertion tracings with varying views (anterior, lateral, and depth/cross-section) can be saved and printed for comparison.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedFeb 2, 2024
Enrollment StartMar 19, 2024
Primary CompletionAug 11, 2024
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 2.4 years ago

Interventions

electromagnetic placement devicedevice

Daily use of an EMPD to verify FT position